TABLE 1

HLA-A*0201+ subjects recruited in the study

SubjectGroupAge (years)*AutoantibodyDisease duration (days)HLA-DRB1 haplotype
T466Type 1 diabetic29Negative62*0101, *1101
T686Type 1 diabetic20IA-2787*0301, *0901
T537Type 1 diabetic14Negative23*0701, *1301
T160Type 1 diabetic24GAD, IA-2, ICA279*0404, *0404
T473Type 1 diabetic26GAD, IA-2638*0404, *1101
T363Type 1 diabetic27GAD, IA-226*0401, *1001
T620Type 1 diabetic9GAD3*0301, *1301
T985Type 1 diabetic35GAD367*0701, *0801
T339Type 1 diabetic14GAD, IA-2Unknown*0404, *0901
T822Type 1 diabetic26GAD, IA-2688*0401, *1302
T657Type 1 diabetic14IA-2551*0701, *1201
T301Type 1 diabetic23GAD, IA-260*0301, *0401
T413Type 1 diabetic13IA-2501*0301, *0401
A200Antibody positive17GAD, IA-2, ICAN/A*0401, *0401
A901Antibody positive12GAD, IA-2N/A*0301, *0404
A309Antibody positive13GAD, IA-2N/A*0301, *0401
A372Antibody positive17GAD, IA-2N/A*0401, *1301
A284Antibody positive36GAD, IA-2N/A*0401, *0404
A519Antibody positive22GADN/A*1501, *1501
C387Control43NegativeN/A*1301, *0404
C552Control29NegativeN/A*0301, *0404
C530Control51NegativeN/A*1301, *1501
C573Control23NegativeN/A*1102, *1101
C363Control50NegativeN/AND
C151Control31NegativeN/A*0901, *1602
C946Control50NegativeN/AND
C860Control19NegativeN/A*1301, *1501
  • *

    * Age at time of blood collection;

  • presence of autoantibodies to GAD65, IA-2, or islet cell Ab;

  • duration of disease at time of blood collection. ICA, islet cell Ab; ND, not determined at time of submission.